Article: Cantel Medical's Crosstex Subsidiary Launches New Specially Treated Face Mask Effective Against H1N1 Influenza

To: MEDICAL EDITORS

Contact: Andrew A. Krakauer, President and CEO of Cantel Medical Corp. , +1-973-890-7220; or Richard E. Moyer of Cameron Associates, Inc., +1-212-554-5466, richard@cameronassoc.com

LITTLE FALLS, N.J., Oct. 13 /PRNewswire-FirstCall/ -- CANTEL MEDICAL CORP.(NYSE: CMN), through its Crosstex International subsidiary, has launched a unique face mask treated with BIOSAFE((R))antimicrobial in markets outside the United States. Crosstex' new BIOSAFE-treated Ultra Sensitive face masks begin to reduce microorganisms, such as MRSA, VRE and Staph, immediately upon contact. These treated face masks have proven to be effective against Influenza A strains, such as seasonal flu and the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!